The global pharmaceutical sector is undergoing a massive redistribution of capital. Between 2025 and 2030, an estimated $236 billion to […]
Buying Smart: The No-Nonsense Guide to Pharma Procurement Read Post »
Why Parallel Proceedings Matter More Than Ever Pharmaceutical patent litigation has always been expensive and slow. What changed after the
Part I: The Generic Drug Market in Numbers Global Market Size and Growth Projections The global generic drugs market was
The Thicket Defined: What You’re Actually Fighting A biologic patent thicket is not a portfolio. It is a deliberate system
Biologic Patent Thickets: How They Work, Why They’re Losing, and What Comes Next Read Post »
Executive Summary The pharmaceutical industry runs on a contradiction that has defined the last 25 years. The science has never
1. Why Patent Database Literacy Is a Competitive Asset Patent information does not merely describe a drug’s legal status. It
Drug repurposing has moved well past the era of accidental bedside observations. Today, systematic computational platforms screen millions of compound-indication
Computational Drug Repurposing: The Complete IP, Technology, and Investment Guide Read Post »
Who actually controls what a drug costs at the pharmacy counter? It is not the manufacturer who sets the list
Executive Summary Pharmaceutical procurement costs at the average U.S. hospital nearly doubled between 2014 and 2021, climbing from $10.21 million
Sign in or create a free account to read this DrugPatentWatch article
